Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.34%40B | 11.51%10.72B | 14.29%10.17B | 9.33%9.59B | 10.15%9.51B | 10.02%35.93B | 11.71%9.62B | 9.57%8.9B | 9.89%8.78B | 8.80%8.63B |
| Operating revenue | 11.20%51.7B | 12.37%13.8B | 12.58%13.12B | 9.89%12.39B | 9.79%12.4B | 9.47%46.49B | 8.61%12.28B | 8.95%11.65B | 9.06%11.28B | 11.40%11.29B |
| Cost of revenue | 11.55%7.86B | 9.03%1.98B | 11.28%1.97B | 4.97%1.88B | 21.69%2.02B | 7.23%7.04B | 7.20%1.82B | 6.61%1.77B | 5.79%1.79B | 9.57%1.66B |
| Gross profit | 11.29%32.15B | 12.09%8.74B | 15.04%8.2B | 10.45%7.71B | 7.40%7.49B | 10.73%28.88B | 12.81%7.8B | 10.33%7.13B | 11.00%6.98B | 8.61%6.97B |
| Operating expense | 15.79%5.59B | 17.42%1.69B | 19.64%1.41B | 6.59%1.28B | 19.88%1.21B | 16.06%4.83B | 16.68%1.44B | 20.12%1.18B | 25.55%1.2B | 2.12%1.01B |
| Selling and administrative expenses | 15.19%4.37B | 17.91%1.38B | 19.52%1.09B | 2.42%973M | 21.73%930M | 17.94%3.79B | 18.12%1.17B | 22.58%912M | 31.76%950M | 0.13%764M |
| -Selling and marketing expense | 7.95%1.68B | 4.54%576M | 11.38%421M | 12.72%381M | 4.44%306M | 16.33%1.56B | 36.72%551M | 27.27%378M | 9.39%338M | -11.75%293M |
| -General and administrative expense | 20.24%2.69B | 29.87%800M | 25.28%669M | -3.27%592M | 32.48%624M | 19.09%2.23B | 5.30%616M | 19.46%534M | 48.54%612M | 9.28%471M |
| Depreciation amortization depletion | 17.99%1.22B | 15.33%316M | 20.08%317M | 22.49%305M | 14.17%282M | 9.65%1.03B | 10.93%274M | 12.34%264M | 6.41%249M | 8.81%247M |
| -Depreciation and amortization | 17.99%1.22B | 15.33%316M | 20.08%317M | 22.49%305M | 14.17%282M | 9.65%1.03B | 10.93%274M | 12.34%264M | 6.41%249M | 8.81%247M |
| Operating profit | 10.39%26.56B | 10.88%7.05B | 14.13%6.79B | 11.26%6.44B | 5.28%6.28B | 9.71%24.06B | 11.97%6.36B | 8.58%5.95B | 8.40%5.78B | 9.80%5.96B |
| Net non-operating interest income (expenses) | 8.11%-589M | -19.32%-210M | 80.10%-39M | -92.68%-158M | 2.67%-182M | 0.47%-641M | 3.83%-176M | -7.69%-196M | 42.25%-82M | -36.50%-187M |
| Non-operating interest expense | -8.11%589M | 19.32%210M | -80.10%39M | 92.68%158M | -2.67%182M | -0.47%641M | -3.83%176M | 7.69%196M | -42.25%82M | 36.50%187M |
| Other net income (expenses) | -454.60%-1.77B | -426.98%-618M | -279.49%-420M | -343.92%-839M | -60.90%104M | 303.25%500M | 35.00%189M | 252.94%234M | -325.00%-189M | 183.91%266M |
| Gain on sale of security | -17.98%789M | 43.22%285M | -21.05%195M | -33.20%161M | -46.18%148M | 41.26%962M | -26.02%199M | -18.75%247M | 186.90%241M | 1,045.83%275M |
| Special income (charges) | -454.55%-2.56B | -8,930.00%-903M | -4,630.77%-615M | -132.56%-1B | -388.89%-44M | 50.16%-462M | 92.25%-10M | 97.16%-13M | ---430M | 97.36%-9M |
| -Less:Other special charges | 454.55%2.56B | 8,930.00%903M | 4,630.77%615M | 132.56%1B | 388.89%44M | -50.16%462M | -92.25%10M | -97.16%13M | --430M | -97.36%9M |
| Income before tax | 1.16%24.19B | -2.34%6.22B | 5.74%6.33B | -1.36%5.44B | 2.62%6.2B | 13.69%23.92B | 13.06%6.37B | 16.38%5.99B | 4.45%5.51B | 21.40%6.04B |
| Income tax | -0.89%4.14B | 7.50%1.13B | -5.01%1.06B | 1.29%861M | -6.16%1.08B | 10.87%4.17B | 10.37%1.05B | 12.83%1.12B | -16.75%850M | 44.36%1.15B |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 1.60%20.06B | -4.29%5.09B | 8.21%5.27B | -1.84%4.58B | 4.68%5.12B | 14.30%19.74B | 13.61%5.32B | 17.23%4.87B | 9.54%4.66B | 17.01%4.89B |
| Net income continuous operations | 1.60%20.06B | -4.29%5.09B | 8.21%5.27B | -1.84%4.58B | 4.68%5.12B | 14.30%19.74B | 13.61%5.32B | 17.23%4.87B | 9.54%4.66B | 17.01%4.89B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 1.60%20.06B | -4.29%5.09B | 8.21%5.27B | -1.84%4.58B | 4.68%5.12B | 14.30%19.74B | 13.61%5.32B | 17.23%4.87B | 9.54%4.66B | 17.01%4.89B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | -28.32%205M | -30.00%49M | -26.39%53M | -32.86%47M | -25.68%55M | 0.70%286M | -2.78%70M | 9.09%72M | -1.41%70M | 0.00%74M |
| Net income attributable to common stockholders | 2.04%19.85B | -3.94%5.04B | 8.73%5.22B | -1.37%4.53B | 5.15%5.06B | 14.53%19.46B | 13.86%5.25B | 17.36%4.8B | 9.72%4.59B | 17.32%4.82B |
| Diluted earnings per share | 4.93%0.7096 | -1.50%0.1819 | 12.08%0.1868 | 1.31%0.1611 | 7.95%0.1791 | 17.49%0.6763 | 17.18%0.1847 | 20.00%0.1666 | 12.25%0.159 | 20.10%0.166 |
| Basic earnings per share | 4.83%0.7083 | -1.13%0.1819 | 12.08%0.1868 | 1.31%0.1611 | 7.95%0.1791 | 17.51%0.6756 | 16.74%0.184 | 20.00%0.1666 | 12.81%0.159 | 20.10%0.166 |
| Dividend per share | 8.66%0.1582 | 10.94%0.0398 | 9.18%0.0395 | 5.01%0.0387 | 9.58%0.0402 | 12.40%0.1456 | 11.36%0.0358 | 11.55%0.0362 | 13.49%0.0369 | 13.21%0.0367 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.